1. A versatile and practical synthesis toward the development of novel HIV-1 integrase inhibitors
- Author
-
Giulia Vignaroli, Encarna Gonzalo, Zeger Debyser, Silvio Massa, Cristina Tintori, Maurizio Botta, José A. Esté, Frauke Christ, Marta Rinaldi, Anna Innitzer, and Luigi Franchi
- Subjects
Models, Molecular ,Spectrometry, Mass, Electrospray Ionization ,Magnetic Resonance Spectroscopy ,Drug Evaluation, Preclinical ,Integrase inhibitor ,HIV Integrase ,01 natural sciences ,Biochemistry ,Cell Line ,03 medical and health sciences ,antiviral agents ,inhibitors ,Drug Discovery ,medicine ,Humans ,HIV Integrase Inhibitors ,General Pharmacology, Toxicology and Pharmaceutics ,030304 developmental biology ,Pharmacology ,0303 health sciences ,biology ,HIV ,integrase ,010405 organic chemistry ,Organic Chemistry ,Raltegravir ,Combinatorial chemistry ,0104 chemical sciences ,3. Good health ,Integrase ,DNA binding site ,Viral replication ,Cell culture ,Docking (molecular) ,biology.protein ,Hiv 1 integrase ,Molecular Medicine ,medicine.drug - Abstract
As a continuation of our previous work, which resulted in the identification of a new hit compound as an HIV-1 integrase inhibitor, three novel series of salicylic acid derivatives were synthesized using three versatile and practical synthetic strategies and were assayed for their capacity to inhibit the catalytic activity of HIV-1 integrase. Biological evaluations revealed that some of the synthesized compounds possess good inhibitory potency in enzymatic assays and are able to inhibit viral replication in MT-4 cells at low micromolar concentrations. Finally, docking studies were conducted to analyze the binding mode of the synthesized compounds within the DNA binding site of integrase in order to refine their structure-activity relationships.
- Published
- 2011
- Full Text
- View/download PDF